These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23856817)

  • 1. Immunotherapy: Modified proinsulin to treat T1DM.
    Geach T
    Nat Rev Endocrinol; 2013 Sep; 9(9):503. PubMed ID: 23856817
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.
    Roep BO; Solvason N; Gottlieb PA; Abreu JRF; Harrison LC; Eisenbarth GS; Yu L; Leviten M; Hagopian WA; Buse JB; von Herrath M; Quan J; King RS; Robinson WH; Utz PJ; Garren H; ; Steinman L
    Sci Transl Med; 2013 Jun; 5(191):191ra82. PubMed ID: 23803704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.
    Gottlieb P; Utz PJ; Robinson W; Steinman L
    Clin Immunol; 2013 Dec; 149(3):297-306. PubMed ID: 24094739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting proinsulin-reactive CD8+ T cells: a new direction for type 1 diabetes treatment.
    Abreu JR; Roep BO
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1001-3. PubMed ID: 24168405
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
    Alhadj Ali M; Liu YF; Arif S; Tatovic D; Shariff H; Gibson VB; Yusuf N; Baptista R; Eichmann M; Petrov N; Heck S; Yang JHM; Tree TIM; Pujol-Autonell I; Yeo L; Baumard L; Stenson R; Howell A; Clark A; Boult Z; Powrie J; Adams L; Wong FS; Luzio S; Dunseath G; Green K; O'Keefe A; Bayly G; Thorogood N; Andrews R; Leech N; Joseph F; Nair S; Seal S; Cheung H; Beam C; Hills R; Peakman M; Dayan CM
    Sci Transl Med; 2017 Aug; 9(402):. PubMed ID: 28794283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
    So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
    Gliwiński M; Iwaszkiewicz-Grześ D; Wołoszyn-Durkiewicz A; Tarnowska M; Żalińska M; Hennig M; Zielińska H; Dukat-Mazurek A; Zielkowska-Dębska J; Zieliński M; Jaźwińska-Curyłło A; Owczuk R; Jarosz-Chobot P; Bossowski A; Szadkowska A; Młynarski W; Marek-Trzonkowska N; Moszkowska G; Siebert J; Myśliwiec M; Trzonkowski P
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32098895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus.
    Hou WR; Xie SN; Wang HJ; Su YY; Lu JL; Li LL; Zhang SS; Xiang M
    Pharmacol Res; 2011 Apr; 63(4):320-7. PubMed ID: 21185938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.
    Yu C; Burns JC; Robinson WH; Utz PJ; Ho PP; Steinman L; Frey AB
    J Diabetes Res; 2016; 2016():9083103. PubMed ID: 27069933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells--report of the IDS T Cell Workshop Committee.
    Pinkse GG; Boitard C; Tree TI; Peakman M; Roep BO
    Ann N Y Acad Sci; 2006 Oct; 1079():19-23. PubMed ID: 17130527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of circulating proinsulin and C-peptide.
    Rubenstein AH; Steiner DF; Horwitz DL; Mako ME; Block MB; Starr JI; Kuzuya H; Melani F
    Recent Prog Horm Res; 1976; 33():435-75. PubMed ID: 198859
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral Proinsulin Expression Controls Low-Avidity Proinsulin-Reactive CD8 T Cells in Type 1 Diabetes.
    Thayer TC; Pearson JA; De Leenheer E; Hanna SJ; Boldison J; Davies J; Tsui A; Ahmed S; Easton P; Siew LK; Wen L; Wong FS
    Diabetes; 2016 Nov; 65(11):3429-3439. PubMed ID: 27495224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.
    Gibson VB; Nikolic T; Pearce VQ; Demengeot J; Roep BO; Peakman M
    Clin Exp Immunol; 2015 Dec; 182(3):251-60. PubMed ID: 26206289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombination of RegIII-proinsulin-pBudCE4.1 plasmid and its therapeutic effect on STZ-induced type 1 diabetes mellitus].
    Hou WR; Xie SN; Lu JL; Xi W; Luo X; Xiang M
    Yao Xue Xue Bao; 2010 Aug; 45(8):987-94. PubMed ID: 21351584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin biosynthesis and C-peptide. Practical applications from basic research.
    Sperling MA
    Am J Dis Child; 1980 Dec; 134(12):1119-21. PubMed ID: 7004174
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro conversion of proinsulin to insulin by cathepsin B and role of C-peptide.
    Puri RB; Anjaneyulu K; Kidwai JR; Mohan Rao VK
    Acta Diabetol Lat; 1978; 15(5-6):243-50. PubMed ID: 373354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emptying the Pool: Modular Insulin Secretion From the Pancreas.
    Rizzo MA
    Diabetes; 2016 Mar; 65(3):542-4. PubMed ID: 26908903
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical and biological aspects of insulin and proinsulin.
    Steiner DF; Terris S; Chan SJ; Rubenstein AH
    Acta Med Scand Suppl; 1976; 601():55-107. PubMed ID: 16981321
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy: Immunotherapy advance for T1DM.
    Greenhill C
    Nat Rev Endocrinol; 2017 Oct; 13(10):564. PubMed ID: 28849787
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of type 1 diabetes mellitus to preserve insulin secretion.
    Herold KC
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):93-111, ix. PubMed ID: 15053897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.